Reports
Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
The global topical antibiotic pharmaceuticals market reached a value of USD 5.61 billion in 2020. The industry is further expected to grow at a CAGR of 3.8% in the forecast period of 2021-2026.
The global topical antibiotic pharmaceuticals industry is primarily being driven by North America. Extensive research on the assessment of the effectiveness and protection of the generic components used in antibiotic pharmaceuticals has become a key component of the growth of the regional industry. The major contribution of North America and Europe to the market is mainly due to the considerably high use of pharmaceutical preparations in the regions in contrast to the Asia Pacific and the rest of the world, which are still firmly rooted in using traditional therapies for topical disease conditions.
Topical antibiotic pharmaceuticals are used to treat skin infections and are widely used as creams and ointments. Topical antibiotics are agents that kill or inhibit the growth of their responsive micro-organisms. Few topical antibiotics can be marketed by doctors without a prescription and can be contained in many kinds, including onions, creams, sprays, and powders. They avoid infections caused by minor scrapes, burns, and cuts in bacteria. The antibiotic treatment of mild injuries permits quicker recovery. If the lesions remain untreated, the bacteria multiply and cause redness, scratching, swelling, oozing, and pain.
Based on form, the market can be divided into:
The types of the product can be divided into prescription and OTC. Topical antibiotic pharmaceuticals find wide applications in the following segments:
The distribution channels can be categorised as follows:
The regional markets for topical antibiotic pharmaceuticals can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Patients that have inadequate hygiene, a weak immune system, and an infected epidermis and close contact with people with epidermal disease are vulnerable to illness. Thus, the rising awareness of topical antibiotic pharmaceuticals is expected to boost the market demand. Technological advancements are considered to play a crucial role in the growing demand for the product. Antibiotic pharmaceuticals are among the most commonly used product by the consumers. Topical antibiotic pharmaceuticals are widely used in a number of conditions, from infections in cuts and in mild to severe acne cases. A substantial increase in awareness of these OTC products is further driving the growth of the market.
The report gives a detailed analysis of the following key players in the global topical antibiotic pharmaceuticals market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Topical Antibiotic Pharmaceuticals Market Analysis
8.1 Key Industry Highlights
8.2 Global Topical Antibiotic Pharmaceuticals Historical Market (2016-2020)
8.3 Global Topical Antibiotic Pharmaceuticals Market Forecast (2021-2026)
8.4 Global Topical Antibiotic Pharmaceuticals Market by Form
8.4.1 Ointment
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Cream
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Suspension
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Powder
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Gel
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2016-2020)
8.4.5.3 Forecast Trend (2021-2026)
8.4.6 Others
8.5 Global Topical Antibiotic Pharmaceuticals Market by Type
8.5.1 Prescription
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 OTC
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.6 Global Topical Antibiotic Pharmaceuticals Market by Application
8.6.1 Skin Infection
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Eye Infection
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Bromhidrosis
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.7 Global Topical Antibiotic Pharmaceuticals Market by Distribution Channel
8.7.1 Hospitals Pharmacies
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2016-2020)
8.7.1.3 Forecast Trend (2021-2026)
8.7.2 Retail Pharmacies
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2016-2020)
8.7.2.3 Forecast Trend (2021-2026)
8.7.3 Online
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2016-2020)
8.7.3.3 Forecast Trend (2021-2026)
8.7.4 Others
8.8 Global Topical Antibiotic Pharmaceuticals Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Taro Pharmaceutical Industries Ltd.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Glenmark Pharmaceuticals Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 GlaxoSmithKline plc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Novartis AG
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Almirall, S.A
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Medimetriks Pharmaceuticals, Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operations Involved
2 Project Requirements and Cost Analysis
2.1 Land, Location, and Site Development
2.2 Construction
2.3 Plant Machinery
2.4 Cost of Raw Materials
2.5 Packaging
2.6 Transportation
2.7 Utilities
2.8 Manpower
2.9 Other Capital Investments
List of Figures and Tables
1. Global Topical Antibiotic Pharmaceuticals Market: Key Industry Highlights, 2016 and 2026
2. Global Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Form (USD Billion), 2016-2020
3. Global Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Form (USD Billion), 2021-2026
4. Global Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Type (USD Billion), 2016-2020
5. Global Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Type (USD Billion), 2021-2026
6. Global Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Application (USD Billion), 2016-2020
7. Global Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Application (USD Billion), 2021-2026
8. Global Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
9. Global Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
10. Global Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Region (USD Billion), 2016-2020
11. Global Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Region (USD Billion), 2021-2026
12. North America Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
13. North America Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Europe Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Europe Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Asia Pacific Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Asia Pacific Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Latin America Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Latin America Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Middle East and Africa Topical Antibiotic Pharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
21. Middle East and Africa Topical Antibiotic Pharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
22. Global Topical Antibiotic Pharmaceuticals Market Structure
In 2020, the global topical antibiotic pharmaceuticals market attained a value of nearly USD 5.61 billion.
The market is projected to grow at a CAGR of 3.8% between 2021 and 2026.
The growth of the market is supported by drivers like rising population, increased disposable incomes, rising awareness of treatment options, and the rising applications of the product.
The rising technological advancements are an important industry trend driving the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading forms of topical antibiotic pharmaceuticals in the market are ointment, cream, suspension, powder, and gel, among others.
The significant types of topical antibiotic pharmaceuticals in the industry are prescription and OTC.
The major application segments in the market are skin infection, eye infection, and bromhidrosis, among others.
The leading distribution channels in the industry are hospital pharmacies, retail pharmacies, and online, among others.
The major players in the industry are Taro Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Inc., GlaxoSmithKline plc., Novartis AG, Almirall, S.A, and Medimetriks Pharmaceuticals, Inc., among others.
The global topical antibiotic pharmaceuticals market attained a value of USD 5.61 billion in 2020, driven by the growing awareness of treatment options. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 3.8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By form, the market is divided into ointment, cream, suspension, powder, and gel, among others. Based on type, the industry is bifurcated into prescription and OTC. On the basis of application, the market is segmented into skin infection, eye infection, and bromhidrosis, among others. By distribution channel, the industry is categorised into hospital pharmacies, retail pharmacies, and online, among others. The major regional markets for topical antibiotic pharmaceuticals are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Taro Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Inc., GlaxoSmithKline plc., Novartis AG, Almirall, S.A, and Medimetriks Pharmaceuticals, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.